Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00184 |
| Species: | Homo sapiens |
| Position : | chr1:42614062-42616745 |
| Year: | 2022 |
| Title: | A beta-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | colorectal cancer |
| PMID: | 34954189 |
| MONDO: | MONDO:0005176 |
| Tissue: | Colon |
| Tissue Ontology ID: | UBERON:0001155 |
| Cell Source: | HCT116 |
| CVCL ID: | CVCL_0291 |
| Cell Type: | colorectal carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, CRISPRi, CRISPRa, ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | GUCA2A |
| TF name : |
| Regulatory State : | Silenced |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00185 | chr1:42614062-42616745 | Bone Marrow | myeloid leukemia cell | acute myeloid leukemia |